Search results
Results from the WOW.Com Content Network
In April 2017, Neuralink announced that it was aiming to make devices to treat serious brain diseases in the short term, with the eventual goal of human enhancement, sometimes called transhumanism. [ 22 ] [ 10 ] [ 23 ] Musk said his interest in the idea partly stemmed from the concept of " neural lace " in the fictional universe in The Culture ...
Elon Reeve Musk (/ ˈ iː l ɒ n m ʌ s k /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. He is also known for his ownership of X Corp. (the company that operates the social media platform X, formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
This is a timeline of the development of prophylactic human vaccines. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became available on the market. Although vaccines exist for the diseases listed below, only smallpox has
Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer ...
Neuralink was formed in 2016, in the hope of creating a new way for humans to interface with machines. Mr Musk has suggested it could offer a way for people to integrate virtual reality with their ...
The investigation has come at a time of growing employee dissent about Neuralink’s animal testing, including complaints that pressure from CEO Musk to accelerate development has resulted in ...
The goal of Neuralink is to develop brain machine-interfaces to help people with paralysis. To help run Neuralink Musk called in the help of Shivon Zilis, who previously worked at Tesla, ...
Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). [10] [11] It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor [6] that is designed to bind to the fusion protein on the surface of the RSV virus.